Peter Stålberg Selected Research

(R)- N- ((4- methoxy- 6- methyl- 2- oxo- 1,2- dihydropyridin- 3- yl)methyl)- 2- methyl- 1- (1- (1- (2,2,2- trifluoroethyl)piperidin- 4- yl)ethyl)- 1H- indole- 3- carboxamide

11/2021

EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Stålberg Research Topics

Disease

34	Neoplasms (Cancer) 11/2021 - 05/2004
9	Neoplasm Metastasis (Metastasis) 11/2021 - 05/2008
6	Multiple Endocrine Neoplasia Type 1 01/2021 - 05/2004
5	Carcinogenesis 01/2021 - 05/2003
5	Neuroendocrine Tumors (Neuroendocrine Tumor) 07/2018 - 08/2012
4	Adenoma (Adenomas) 01/2016 - 01/2012
3	Parathyroid Neoplasms (Parathyroid Neoplasm) 06/2021 - 11/2009
3	Hypocalcemia 03/2016 - 11/2009
3	Carcinoma (Carcinomatosis) 01/2016 - 06/2014
2	Hypoparathyroidism 12/2021 - 03/2016
2	Cushing Syndrome 12/2021 - 06/2014
2	Adrenocortical Carcinoma 01/2021 - 12/2018
2	Thyroid Neoplasms (Thyroid Cancer) 01/2020 - 10/2009
2	Pheochromocytoma 12/2018 - 09/2010
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2016
2	Peritoneal Neoplasms 01/2018 - 01/2018
2	Hypertension (High Blood Pressure) 01/2017 - 01/2012
2	Primary Hyperparathyroidism 03/2016 - 01/2016
2	Multiple Endocrine Neoplasia (Multiple Endocrine Adenomatosis) 01/2012 - 01/2007
2	Carcinoid Tumor (Carcinoid) 06/2010 - 05/2008
2	Insulinoma 04/2009 - 01/2007
1	Follicular Adenocarcinoma 01/2020
1	Lymphatic Metastasis 01/2020
1	Anaplastic Thyroid Carcinoma 01/2020
1	Microsatellite Instability 01/2020
1	Paraganglioma (Paragangliomas) 12/2018
1	Epilepsy (Aura) 07/2016
1	Primitive Neuroectodermal Tumors (PNET) 02/2016
1	Hypercalcemia (Milk Alkali Syndrome) 01/2016
1	Renal Insufficiency (Renal Failure) 04/2014
1	Secondary Hyperparathyroidism 04/2014
1	Goiter 02/2014
1	Graves Disease (Basedow Disease) 02/2014
1	Hyperaldosteronism (Conn Syndrome) 01/2012
1	Hyperplasia 01/2012
1	Zollinger-Ellison Syndrome (Syndrome, Zollinger-Ellison) 01/2012
1	Pancreatitis 06/2010

Drug/Important Bio-Agent (IBA)

8	Proteins (Proteins, Gene)FDA Link 01/2017 - 05/2003
6	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 10/2009
5	Messenger RNA (mRNA)IBA 08/2019 - 09/2006
4	Biomarkers (Surrogate Marker)IBA 01/2017 - 09/2010
3	Vitamin D FDA LinkGeneric 12/2021 - 02/2014
3	CalciumIBA 12/2021 - 02/2014
3	5-hydroxymethylcytosineIBA 07/2018 - 01/2016
3	Hormones (Hormone)IBA 02/2016 - 09/2006
3	AldosteroneIBA 01/2016 - 01/2012
2	Histone MethyltransferasesIBA 11/2021 - 04/2014
2	MicroRNAs (MicroRNA)IBA 01/2021 - 09/2010
2	RNA (Ribonucleic Acid)IBA 12/2018 - 08/2011
2	Hydroxyindoleacetic AcidIBA 01/2018 - 05/2008
2	Pharmaceutical PreparationsIBA 01/2018 - 07/2016
2	Sirolimus (Rapamycin)FDA Link 01/2018 - 01/2017
2	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2016 - 10/2015
2	CateninsIBA 01/2016 - 04/2014
2	Parathyroid Hormone (Parathormone)IBA 01/2016 - 02/2014
2	Histones (Histone)IBA 04/2014 - 04/2014
2	GhrelinIBA 01/2007 - 09/2006
2	Ghrelin ReceptorsIBA 01/2007 - 09/2006
1	(R)- N- ((4- methoxy- 6- methyl- 2- oxo- 1,2- dihydropyridin- 3- yl)methyl)- 2- methyl- 1- (1- (1- (2,2,2- trifluoroethyl)piperidin- 4- yl)ethyl)- 1H- indole- 3- carboxamideIBA 11/2021
1	Enhancer of Zeste Homolog 2 ProteinIBA 11/2021
1	Metformin (Glucophage)FDA LinkGeneric 11/2021
1	GlycosphingolipidsIBA 06/2021
1	RacivirIBA 01/2020
1	prolinedithiocarbamate (PDTC)IBA 01/2020
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2019
1	Tyrosine (L-Tyrosine)FDA Link 08/2019
1	Biocompatible Materials (Biomaterials)IBA 02/2018
1	Protein Kinase InhibitorsIBA 01/2018
1	Chromogranin AIBA 01/2018
1	Edotreotide (SMT 487)IBA 01/2018
1	Phosphotransferases (Kinase)IBA 01/2018
1	CatecholaminesIBA 01/2017
1	AminesIBA 01/2017
1	Peptides (Polypeptides)IBA 01/2017
1	MidkineIBA 01/2017
1	5-Methylcytosine (5 Methylcytosine)IBA 01/2017
1	Insulin (Novolin)FDA Link 07/2016
1	Peptide Hormones (Polypeptide Hormones)IBA 02/2016
1	EnzymesIBA 01/2016
1	ParaffinIBA 01/2016
1	Formaldehyde (Formol)FDA Link 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 06/2014
1	Lysine (L-Lysine)FDA Link 04/2014
1	MethyltransferasesIBA 04/2014
1	ElonginIBA 04/2014
1	Epinephrine (Adrenaline)FDA LinkGeneric 07/2013
1	Norepinephrine (Noradrenaline)FDA LinkGeneric 07/2013
1	SurvivinIBA 06/2012
1	Potassium Channels (Potassium Channel)IBA 01/2012
1	Transforming Growth Factor-beta Type II ReceptorIBA 08/2011

Therapy/Procedure

3	Thyroidectomy 12/2021 - 10/2009
3	Therapeutics 01/2017 - 09/2010
3	Parathyroidectomy 03/2016 - 10/2009
2	Autologous Transplantation 12/2021 - 03/2016
2	Radiofrequency Ablation 08/2012 - 05/2008
1	Adrenalectomy 12/2021
1	Minimally Invasive Surgical Procedures 01/2021
1	Lymph Node Excision (Lymph Node Dissection) 02/2018
1	Laparotomy 01/2018
1	Cholecystectomy 06/2010